Hyperkalaemia, CKD, and a 'heart-healthy' salt substitute
A 64-year-old man with type 2 diabetes, hypertension, and CKD stage 3b (eGFR 38 mL/min/1.73 m²) is referred after potassium rose to 5.7 mmol/L. He takes ramipril 10 mg daily and spironolactone 25 mg daily. HbA1c is 7.9%, BP 148/86 mmHg, sodium 138 mmol/L, bicarbonate 21 mmol/L, phosphate 1.5 mmol/L, and weight 82 kg. He has read that the DASH diet lowers blood pressure and has started using a potassium-based salt substitute, eating two bananas daily, and drinking orange juice each morning. He also reports constipation and takes a psyllium supplement. He asks whether he should switch to a 'heart-healthy' salt and continue DASH. The prescriber is considering stopping spironolactone but has not yet done so.
1. What is your priority judgement about the salt substitute and the DASH advice in this patient?
Read the worked answer
The immediate priority is to reduce hyperkalaemia risk before reinforcing DASH. Potassium-based salt substitutes contain potassium chloride and can add a substantial potassium load, especially when renal excretion is impaired (eGFR 38) and the patient takes both an ACE inhibitor and spironolactone, which further raise potassium. Two bananas and daily orange juice add more. A potassium of 5.7 mmol/L is clinically significant and warrants prompt action. DASH is evidence-based for blood pressure but its standard form is high in potassium, so it must be adapted for CKD rather than abandoned or applied unmodified. The correct judgement is: stop the potassium-based salt substitute now, review the high-potassium foods and supplement, and contact the prescriber about spironolactone and potassium monitoring. Do not tell him to continue the current regimen while 'eating more DASH'; that would be unsafe. Frame the plan as a kidney-adjusted DASH pattern with individualised potassium control.
2. What dietary and medication-related actions would you recommend, and what would you monitor?
Read the worked answer
Diet: stop the potassium chloride salt substitute; replace it with a small amount of ordinary salt if sodium advice permits, or flavour with herbs, spices, lemon, and vinegar. Reduce the daily banana and orange juice to portions agreed with the renal team; choose lower-potassium fruits such as apple, berries, or grapes; avoid high-potassium salt substitutes, potato crisps, and large portions of tomato, potato, and squash. Discuss leaching high-potassium vegetables if culturally appropriate. Do not impose a very restrictive potassium diet without assessing intake, because over-restriction reduces diet quality. Medication: ask the prescriber to review spironolactone and ramipril; do not advise stopping them yourself. Check the psyllium and any other supplements for potassium content. Monitor potassium and renal function closely, plus bicarbonate, phosphate, blood pressure, and glucose. Set a protein target of about 0.8 g/kg/day (66 g/day) if stable CKD without dialysis, individualised with the renal team. Document that the potassium salt substitute was stopped and why.
3. The patient says he feels well and asks why he cannot just keep DASH and use the salt substitute. How do you explain the risk and negotiate a plan?
Read the worked answer
Explain that high potassium can cause dangerous heart rhythm problems even when a person feels well; symptoms are not a reliable warning. Use his numbers: eGFR 38 means reduced potassium excretion, ramipril and spironolactone both raise potassium, and the salt substitute plus bananas and juice add more. A potassium of 5.7 mmol/L is above the usual reference range and needs action. Distinguish the general DASH message from his individual prescription: DASH is a dietary pattern, not a single salt product, and it can be modified for kidney disease. Negotiate a concrete two-week plan: stop the salt substitute today, reduce the high-potassium foods to agreed portions, keep a food and supplement record, and repeat potassium as arranged. Ask him what he is willing to change first and involve the prescriber in medication review. Give written advice and a follow-up contact. Document the discussion, his understanding, and consent to the plan.